208 related articles for article (PubMed ID: 15663508)
1. Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome.
Celebi JT; Ward KM; Wanner M; Polsky D; Kopf AW
Clin Exp Dermatol; 2005 Jan; 30(1):68-70. PubMed ID: 15663508
[TBL] [Abstract][Full Text] [Related]
2. BRAF alterations are associated with complex mutational profiles in malignant melanoma.
Daniotti M; Oggionni M; Ranzani T; Vallacchi V; Campi V; Di Stasi D; Torre GD; Perrone F; Luoni C; Suardi S; Frattini M; Pilotti S; Anichini A; Tragni G; Parmiani G; Pierotti MA; Rodolfo M
Oncogene; 2004 Aug; 23(35):5968-77. PubMed ID: 15195137
[TBL] [Abstract][Full Text] [Related]
3. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
Tachibana I; Smith JS; Sato K; Hosek SM; Kimmel DW; Jenkins RB
Am J Med Genet; 2000 May; 92(2):136-41. PubMed ID: 10797439
[TBL] [Abstract][Full Text] [Related]
4. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
[TBL] [Abstract][Full Text] [Related]
5. Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours.
Marian C; Scope A; Laud K; Friedman E; Pavlotsky F; Yakobson E; Bressac-de Paillerets B; Azizi E
Br J Cancer; 2005 Jun; 92(12):2278-85. PubMed ID: 15928671
[TBL] [Abstract][Full Text] [Related]
6. The genetics of cutaneous melanoma.
Pollock PM; Trent JM
Clin Lab Med; 2000 Dec; 20(4):667-90. PubMed ID: 11221509
[TBL] [Abstract][Full Text] [Related]
7. Use of human tissue to assess the oncogenic activity of melanoma-associated mutations.
Chudnovsky Y; Adams AE; Robbins PB; Lin Q; Khavari PA
Nat Genet; 2005 Jul; 37(7):745-9. PubMed ID: 15951821
[TBL] [Abstract][Full Text] [Related]
8. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation.
Molven A; Grimstvedt MB; Steine SJ; Harland M; Avril MF; Hayward NK; Akslen LA
Genes Chromosomes Cancer; 2005 Sep; 44(1):10-8. PubMed ID: 15880589
[TBL] [Abstract][Full Text] [Related]
9. Novel and recurrent p14 mutations in Italian familial melanoma.
Binni F; Antigoni I; De Simone P; Majore S; Silipo V; Crisi A; Amantea A; Pacchiarini D; Castori M; De Bernardo C; Catricalà C; Grammatico P
Clin Genet; 2010 Jun; 77(6):581-6. PubMed ID: 20132244
[TBL] [Abstract][Full Text] [Related]
10. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
[TBL] [Abstract][Full Text] [Related]
11. Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.
Auroy S; Avril MF; Chompret A; Pham D; Goldstein AM; Bianchi-Scarrà G; Frebourg T; Joly P; Spatz A; Rubino C; Demenais F; Bressac-de Paillerets B;
Genes Chromosomes Cancer; 2001 Nov; 32(3):195-202. PubMed ID: 11579459
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
[TBL] [Abstract][Full Text] [Related]
13. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
Abdel-Rahman MH; Pilarski R; Massengill JB; Christopher BN; Noss R; Davidorf FH
Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
[TBL] [Abstract][Full Text] [Related]
14. The absence of multiple atypical nevi in germline CDKN2A mutations: Comment on "Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome".
Ipenburg NA; Gruis NA; Bergman W; van Kester MS
J Am Acad Dermatol; 2016 Oct; 75(4):e157. PubMed ID: 27646763
[No Abstract] [Full Text] [Related]
15. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
Tucker MA; Fraser MC; Goldstein AM; Struewing JP; King MA; Crawford JT; Chiazze EA; Zametkin DP; Fontaine LS; Clark WH
Cancer; 2002 Jun; 94(12):3192-209. PubMed ID: 12115352
[TBL] [Abstract][Full Text] [Related]
16. CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas.
Holland EA; Schmid H; Kefford RF; Mann GJ
Genes Chromosomes Cancer; 1999 Aug; 25(4):339-48. PubMed ID: 10398427
[TBL] [Abstract][Full Text] [Related]
17. Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: a clinic-based population study.
Platz A; Hansson J; Ringborg U
Int J Cancer; 1998 Sep; 78(1):13-5. PubMed ID: 9724087
[TBL] [Abstract][Full Text] [Related]
18. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2004. A 48-year-old woman with multiple pigmented lesions and a personal and family history of melanoma.
Tsao H; Sober AJ; Niendorf KB; Zembowicz A
N Engl J Med; 2004 Feb; 350(9):924-32. PubMed ID: 14985491
[No Abstract] [Full Text] [Related]
19. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.
Tsao H; Zhang X; Kwitkiwski K; Finkelstein DM; Sober AJ; Haluska FG
Arch Dermatol; 2000 Sep; 136(9):1118-22. PubMed ID: 10987867
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of N-ras, p53, CDKN2A (p16(INK4a)), p14(ARF), CDK4, and MC1R genes in human dysplastic melanocytic naevi.
Papp T; Pemsel H; Rollwitz I; Schipper H; Weiss DG; Schiffmann D; Zimmermann R
J Med Genet; 2003 Feb; 40(2):E14. PubMed ID: 12566532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
